Sandy Feng

Sandy Feng, MD, PhD, a transplant surgeon at the University of California, San Francisco (UCSF) School of Medicine, specializes in liver, kidney, and pancreas transplants while leading groundbreaking research on transplantation tolerance. She completed her medical degree at Stanford University School of Medicine (1990) and a doctorate in molecular biology at the University of Cambridge under a Marshall Scholarship. Her clinical and research contributions are supported by NIH grants.

• Harvard College (BA)
• University of Cambridge (PhD, Molecular Biology)
• Stanford University School of Medicine (MD)
• Brigham and Women's Hospital (General Surgery Residency)
• UCSF (Transplant Fellowship)

Dr. Feng's research focuses on minimizing immunosuppressive drug use through tolerance induction, with leadership in NIH-funded multicenter clinical trials like EVR and EPO for Liver Transplant Tolerance. Her work spans transplant immunology, organ allocation, and long-term graft outcomes, often published in top journals such as New England Journal of Medicine and American Journal of Transplantation. She has served on editorial boards and organized national conferences addressing transplant disparities.

Her recent publications highlight trends in liver-kidney transplantation, normothermic machine perfusion, and transplantation during pandemics. Dr. Feng was elected to the National Academy of Medicine (2023) for her contributions. She mentors surgical teams and collaborates with institutions globally, balancing clinical practice with academic leadership.